The global orthopedic biomaterials market size accounted for USD 82.38 billion in 2022 and is projected to hit around USD 212.6 billion by 2030, growing at a CAGR of 12.58% from 2022 to 2030.
The global orthopedic biomaterials market size accounted for USD 82.38 billion in 2022 and is projected to hit around USD 212.6 billion by 2030, growing at a CAGR of 12.58% from 2022 to 2030.
The global orthopedic biomaterials market is expanding due to increased injuries from sports and road accidents as well as rising demand for orthopedic implants.
Biomaterials are widely employed in medical treatments, including orthopedic surgery. Orthopedic biomaterials, made of natural or artificial substances, aid in restoring the structural integrity of bones that have been harmed by trauma or disease. Orthopedic biomaterials are included in the human body as parts of apparatuses intended to carry out specific biological tasks by replacing or mending different tissue, including ligaments, cartilage, tendons, bones, and others. Applications for the product include viscosupplementation, bio-resorbable tissue fixation, ortho biologics, joint replacement, and spine implants.
Download a Free Sample Copy of this Report@ https://www.precedenceresearch.com/sample/1107
Market Growth
Increased prevalence of musculoskeletal disorders and chronic skeletal problems are driving up product demand and fueling market expansion. It is anticipated that the demand would increase due to the growing elderly population, who are particularly vulnerable to these illnesses. Joint replacements, spine implants, ortho biologics, and bio-resorbable tissue fixation are just a few applications for orthopedic biomaterials that are being employed more and more. Due to a number of causes, it is anticipated that the demand for orthopedic biomaterials would increase significantly throughout the projected period (2022-2030).
Orthopedic Biomaterials Market Report Scope
| Report Coverage | Details |
| Market Size In 2022 | US$ 82.38 Billion |
| Market Size By 2030 | US$ 212.6 Billion |
| Growth Rate From 2022 to 2030 | CAGR of 12.58% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Material, Application, End User, and Regions |
Report Highlight
- Material Insight: The market has been divided into ceramics and bioactive glass, calcium phosphate cement, composites, metal, and polymers based on the kind of material. In 2018, the ceramics and bioactive glass market segment held a monopoly due to the widespread use of ceramics in numerous procedures for the restoration of hard tissues. The polymer segment is expected to experience a considerable increase over the forecast period due to the rising usage of polymer in bone cement and load-bearing areas for total joint arthroplasties.
- Application Insight: Numerous uses for orthopedic biomaterials include viscosupplementation, absorbable tissue fixation, joint replacement/reconstruction, orthopedic implants, and joint orthobiologics. The orthopedic implant category dominated the market in 2021 and continued to do so throughout the anticipated time frame.
Regional Analysis
North America dominated the market in 2021, and it is estimated that it will hold this position throughout the forecasted period while expanding at a lucrative CAGR. Asia Pacific is estimated to develop at the fastest rate during the projected period, with a CAGR of 11.9%. One of the primary factors driving the regional market is the rise in the incidence of bone degenerative diseases and bone disorders in low- and middle-income countries. Over the forecast period, the orthopedic biomaterials market worldwide is anticipated to grow at the quickest rate in the Asia Pacific. The Middle East and Africa, however, have less development due to a lack of information and restricted access to medical care. However, a slow but steady increase in spending for the construction of hospitals in the UAE (United Arab Emirates) could support future Middle East prosperity.
Ask Here for Customization@ https://www.precedenceresearch.com/customization/1107
Market Dynamics
Drivers
More people are likely to experience joint diseases because of the rise in the number of elderly people, which will help the industry as a whole grow. The number of people 65 and over was 703 million in 2019, and according to research released by the UN Department of Economic and Social Affairs in 2019, that number is projected to increase to 1.5 billion by the year 2050. The global orthopedic biomaterial market is anticipated to grow during the anticipated period due to the increasing prevalence of musculoskeletal conditions and chronic skeletal muscle problems. In February 2021, 1.71 billion people worldwide were afflicted with musculoskeletal issues, according to the World Health Organization (WHO).
Restraints
Limited reimbursement coverage options, which have led to lower payments for orthopedic implants in many countries, have impeded the market’s growth. Additionally, the lack of reimbursements has forced producers to lower the prices of these products, severely restricting market expansion.
Recent Development
- A definite agreement was struck in November 2019 for Stryker, an American Fortune 500 medical equipment company, to acquire Wright Medical for $5.4 Billion. The orthopedic division of Stryker will benefit from this transaction, and Wright Medical’s biologics and extremities divisions will get further exposure.
- The first spinal implant built from the biomaterial Zfuze, the Xiphos-ZF spinal interbody device, was introduced by DiFusion in November 2019 after receiving FDA authorization.
The prominent players in the orthopedic biomaterials market include:
- Acumed, LLC
- Medtronic plc
- Globus Medical, Inc.
- Stryker Corporation
- Koninklijke DSM N.V.
- Exactech, Inc.
- Johnson & Johnson
- Zimmer Biomet
- Wright Medical Group, Inc.
- NuVasive, Inc.
Market Segmentation
By Material Outlook
- Polymers
- Ceramics & Bioactive Glasses
- Calcium Phosphate Cement
- Composites
- Metal
By Application Outlook
- Orthobiologics
- Orthopedic Implants
- Viscosupplementation
- Joint Replacement
- Bio-resorbable Tissue Fixation
By End User
- Hospitals
- Orthopedic Clinics
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Click Here to View Full Report Table of Contents
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1107
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333